Natco Gets Favourable Ruling in US
Hyderabad-based Natco Pharma Ltd. has been awarded a favourable judgment in the US Court of Appeals for the Federal Circuit ruling on patent-related to Teva’s Copaxone (treat multiple sclerosis). The court of appeals had reversed a district court’s finding related to Copaxone patent.
“This would essentially mean that Natco could launch the generic version of Copaxone through its marketing partner Mylan Inc during May 2014 subject to FDA approval,” the company said in a release.
Looking for chemical products? Let suppliers reach out to you!
You May Interested In
β-Nicotinamide Adenine Dinucleotide High Quality NAD+ CAS 53-84-9 Exclusive Production Factory CAS NO.53-84-9
$75/UNIT FOB
2026-06-25
-
Life Sciences Industry Overview
The coverage spans the global life sciences industry across pharmaceuticals and food & nutrition, tracking the shift from lowest-cost sourcing to supply continuity, quality, and risk management, along with product trends and the growing edge of differentiated, globally capable players.Published in: June.2026
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Pharma Quality Excellence Awards 2026 - Celebration and Conclusion
-
Pharma Quality Reimagined: Highlights from the 6th Annual Pharma GMP & Quality Management 2026
-
From Feedmill to Food System: VIV Europe 2026 Addresses the Industry's Most Critical Challenges
-
Urea Prices Surge as India Faces Critical Shortages: Will China’s Export Quotas Provide Relief?
-
Beyond Compliance: Building Quality Maturity
-
India Extends Anti-Dumping Duties on Aniline Imports from China for Five More Years
-
Covestro India and CSIR-NCL Collaborate to Transform Polyurethane Waste
-
The United States Lifts Restrictions on Ethane Exports to China, and Trade Relations Show Signs of Easing
-
India Imposes Anti-Dumping Duties on Chinese vitamin A Palmitate and Insoluble Sulfur Products
-
Indian Government Increases Excise Duty on Petrol and Diesel
Recommend Reading
-
EFSA Confirms Safety of Vitamin E TPGS as Food Additive New Opinion Covers Multiple Use Levels
-
Indian Pharma Urges US to Exempt Generics as 50 Percent Tariffs Loom National Security Probe Sparks Supply Fears
-
Rising API Costs Threaten Drug Prices
-
US Vietnam Trade Deal Slashes Tariffs to 20 Percent Avoids Economic Clash
-
Lilly Bets Bigger on China
-
This Week, China's Acetone Market Continues to Show Weakness (8.15-22)
-
MTBE Market Trends Show Signs of Slowing Down
-
October Anhydrous Hydrogen Fluoride Market Prices Rise in China
-
Phosphate Market Shows Narrow Fluctuations (10.17-10.23)
-
Methanol Market Shows Weak and Fluctuating Trends in China